Literature DB >> 15342907

CD1d-restricted T cell activation by nonlipidic small molecules.

Ildiko Van Rhijn1, David C Young, Jin Seon Im, Steven B Levery, Petr A Illarionov, Gurdyal S Besra, Steven A Porcelli, Jenny Gumperz, Tan-Yun Cheng, D Branch Moody.   

Abstract

In addition to NK T cells expressing invariant Valpha14 or Valpha24 T cell receptors (TCRs), the CD1d-restricted T cell repertoire is comprised of T cells with diverse TCRs that mediate inflammation during autoimmune and infectious disease. Here we describe the isolation of human Valpha24(-) T cells that are activated by antigen and CD1d. Mass spectrometric and NMR studies revealed that the stimulatory compounds were neither peptidic nor lipidic but instead were composed of sulfur and aromatic hydrocarbon rings, corresponding to the general structure of phenyl pentamethyldihydrobenzofuran sulfonates. Studies of the molecular mechanism of T cell activation showed that a clonotypic Valpha2/Vbeta21 TCR transmitted activating signals, which were highly specific for hydroxylation and methylation patterns at the terminal structures of stimulatory compounds. These studies provide evidence for noninvariant CD1d-restricted T cells in humans and identify the complete molecular structure of a nonlipidic small molecule that activates T cells through an alphabeta TCR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342907      PMCID: PMC518797          DOI: 10.1073/pnas.0402838101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.

Authors:  E M Beckman; S A Porcelli; C T Morita; S M Behar; S T Furlong; M B Brenner
Journal:  Nature       Date:  1994-12-15       Impact factor: 49.962

2.  Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production.

Authors:  R Nakagawa; K Motoki; H Nakamura; H Ueno; R Iijima; A Yamauchi; S Tsuyuki; T Inamoto; Y Koezuka
Journal:  Oncol Res       Date:  1998       Impact factor: 5.574

3.  CD1-restricted T cell recognition of microbial lipoglycan antigens.

Authors:  P A Sieling; D Chatterjee; S A Porcelli; T I Prigozy; R J Mazzaccaro; T Soriano; B R Bloom; M B Brenner; M Kronenberg; P J Brennan
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

4.  CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family.

Authors:  E M Beckman; A Melián; S M Behar; P A Sieling; D Chatterjee; S T Furlong; R Matsumoto; J P Rosat; R L Modlin; S A Porcelli
Journal:  J Immunol       Date:  1996-10-01       Impact factor: 5.422

5.  Essential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cells.

Authors:  M Taniguchi; H Koseki; T Tokuhisa; K Masuda; H Sato; E Kondo; T Kawano; J Cui; A Perkes; S Koyasu; Y Makino
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

6.  CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen.

Authors:  S Porcelli; C T Morita; M B Brenner
Journal:  Nature       Date:  1992-12-10       Impact factor: 49.962

7.  Preferential usage of T-cell receptor V beta 17 by dengue virus-specific human T lymphocytes in a donor with immunity to dengue virus type 4.

Authors:  Y Okamoto; S J Gagnon; I Kurane; A M Leporati; F A Ennis
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.

Authors:  Alex Jahng; Igor Maricic; Carlos Aguilera; Susanna Cardell; Ramesh C Halder; Vipin Kumar
Journal:  J Exp Med       Date:  2004-03-29       Impact factor: 14.307

9.  An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.

Authors:  O Lantz; A Bendelac
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

10.  CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice.

Authors:  S Cardell; S Tangri; S Chan; M Kronenberg; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more
  48 in total

1.  Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor.

Authors:  Dirk M Zajonc; Carlos Cantu; Jochen Mattner; Dapeng Zhou; Paul B Savage; Albert Bendelac; Ian A Wilson; Luc Teyton
Journal:  Nat Immunol       Date:  2005-07-10       Impact factor: 25.606

2.  Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure.

Authors:  Melanie J Ragin; Nisebita Sahu; Avery August
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Non-classical natural killer T cells modulate plasmid DNA vaccine antigen expression and vaccine-elicited immune responses by MCP-1 secretion after interaction with a beta2-microglobulin-independent CD1d.

Authors:  Ralf Geiben-Lynn; John R Greenland; Kwesi Frimpong-Boateng; Norman L Letvin
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

Review 4.  Raising the NKT cell family.

Authors:  Dale I Godfrey; Sanda Stankovic; Alan G Baxter
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

Review 5.  Lipid and small-molecule display by CD1 and MR1.

Authors:  Ildiko Van Rhijn; Dale I Godfrey; Jamie Rossjohn; D Branch Moody
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

Review 6.  Mechanisms and Consequences of Antigen Presentation by CD1.

Authors:  Luc Van Kaer; Lan Wu; Sebastian Joyce
Journal:  Trends Immunol       Date:  2016-09-09       Impact factor: 16.687

7.  Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d.

Authors:  Douglass Wu; Dirk M Zajonc; Masakazu Fujio; Barbara A Sullivan; Yuki Kinjo; Mitchell Kronenberg; Ian A Wilson; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

Review 8.  The role of NKT cells in tumor immunity.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

9.  Functional CD1d and/or NKT cell invariant chain transcript in horse, pig, African elephant and guinea pig, but not in ruminants.

Authors:  Frank A Looringh van Beeck; Peter Reinink; Roel Hermsen; Dirk M Zajonc; Marielle J Laven; Axel Fun; Milana Troskie; Nico J Schoemaker; Darshana Morar; Johannes A Lenstra; Lonneke Vervelde; Victor P M G Rutten; Willem van Eden; Ildiko Van Rhijn
Journal:  Mol Immunol       Date:  2009-01-30       Impact factor: 4.407

10.  CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acids.

Authors:  Ildiko Van Rhijn; David C Young; Annemieke De Jong; Jenny Vazquez; Tan-Yun Cheng; Rahul Talekar; Duarte C Barral; Duarte Barral; Luis León; Michael B Brenner; Joel T Katz; Richard Riese; Ruth M Ruprecht; Peter B O'Connor; Catherine E Costello; Steven A Porcelli; Volker Briken; D Branch Moody
Journal:  J Exp Med       Date:  2009-05-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.